Australia -
English -
Department of Health (Therapeutic Goods Administration)
utrogestan 200 progesterone 200 mg soft vaginal capsule blister pack
besins healthcare australia pty ltd - progesterone, quantity: 200 mg - pessary, shell - excipient ingredients: glycerol; lecithin; titanium dioxide; gelatin; purified water; sunflower oil - luteal phase support ? luteal support of assisted reproductive technology (art) cycles,support during pregnancy ? prevention of preterm birth in women with singleton pregnancy who have a short cervix (midtrimester sonographic cervix less than or equal to 25 mm) and/or a history of spontaneous preterm birth. ? treatment of unexplained threatened miscarriage in women with bleeding in the current pregnancy and a history of at least three or more previous miscarriages. use in women with less than three miscarriages may be warranted in those with reduced chances of future pregnancy such as those undergoing ivf treatment with limited viable egg and/or embryo availability or advanced fertility age. however, the benefit of treatment in clinical trials was limited to women with three or more miscarriages. (see section 5 pharmacological properties; clinical trials; threatened unexplained miscarriage)
Armenia -
English -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
crinone
central pharma (contract packing) limited - progesterone - gel vaginal - 80mg/g
Armenia -
English -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
crinone gel vaginal
central pharma (contract packing) limited - progesterone - gel vaginal - 80mg/g
Armenia -
English -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
crinone gel vaginal
central pharma (contract packing) limited - progesterone - gel vaginal - 80mg/g
Armenia -
English -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
crinone gel vaginal
central pharma (contract packing) limited - progesterone - gel vaginal - 80mg/g
United States -
English -
NLM (National Library of Medicine)
crinone- progesterone gel
actavis pharma, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 45 mg in 1.125 g - crinone 8% is indicated for progesterone supplementation or replacement as part of an assisted reproductive technology ("art") treatment for infertile women with progesterone deficiency. crinone 4% is indicated for the treatment of secondary amenorrhea. crinone 8% is indicated for use in women who have failed to respond to treatment with crinone 4%. crinone should not be used in individuals with any of the following conditions: - known sensitivity to crinone (progesterone or any of the other ingredients) - undiagnosed vaginal bleeding - liver dysfunction or disease - known or suspected malignancy of the breast or genital organs - missed abortion - active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thromboembolic disorders
United States -
English -
NLM (National Library of Medicine)
crinone- progesterone gel
columbia laboratories, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 45 mg in 1.125 g - crinone® 8% is indicated for progesterone supplementation or replacement as part of an assisted reproductive technology ("art") treatment for infertile women with progesterone deficiency. crinone® 4% is indicated for the treatment of secondary amenorrhea. crinone® 8% is indicated for use in women who have failed to respond to treatment with crinone® 4%. crinone® should not be used in individuals with any of the following conditions: - known sensitivity to crinone® (progesterone or any of the other ingredients) - undiagnosed vaginal bleeding - liver dysfunction or disease - known or suspected malignancy of the breast or genital organs - missed abortion - active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thromboembolic disorders crinone® progesterone gel 8% ndc 55056-0818-5 15 single-use prefilled applicators each applicator contains 1.45 g of gel and delivers 1.125 g of gel containing 90 mg progesterone. for vaginal use only columbia la
Panama -
English -
Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)
crinone al 8% gel vaginal
merck, s.a - progesterona micronizada - progesterona micronizada....90 mg
United States -
English -
NLM (National Library of Medicine)
crinone- progesterone gel
allergan, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - assisted reproductive technology crinone 8% is indicated for progesterone supplementation or replacement as part of an assisted reproductive technology ("art") treatment for infertile women with progesterone deficiency. secondary amenorrhea crinone 4% is indicated for the treatment of secondary amenorrhea. crinone 8% is indicated for use in women who have failed to respond to treatment with crinone 4%. crinone should not be used in individuals with any of the following conditions: - known sensitivity to crinone (progesterone or any of the other ingredients) - undiagnosed vaginal bleeding - liver dysfunction or disease - known or suspected malignancy of the breast or genital organs - missed abortion - active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thromboembolic disorders crinone ® 4% and crinone ® 8% ("kri-noan") (progesterone gel) for vaginal use only you will need the following supplies: see figure a. step 1. remove the applicator from the
